Immunovo B.V. Alternatives & Competitors

12 companies similar to Immunovo B.V. — Advancing Cancer Treatment with Pioneering Immune Activation Technology

Apexigen

Creating Transformative Immunotherapies for Patients with Cancer

11 Post-IPO Equity $175.80M

San Carlos, United States

Biopharma Biotechnology +2

Memgen, Inc.

Memgen's Vision: Develop Life-Saving Cancer Immunotherapies

7 Venture round

Houston, United States

Biotechnology Health Care +2

OncoPep, Inc.

To develop and commercialize targeted immuno-therapeutics which prevent the progression of...

4 Series D $28.44M

Boston, United States

Biotechnology Health Care +1

Bolt Biotherapeutics, Inc.

Plans to develop a novel format for T-cell mediated anti-tumour therapy

47 IPO $413.50M

Redwood City, United Stat...

Biotechnology Pharmaceutical

Track all Immunovo B.V. competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

Brenus Pharma

Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣

21 Series A $40.10M

Lyon, France

Biotechnology Pharmaceutical

OSE Immunotherapeutics

Immuno-Oncology and Immuno-Inflammation - Breakthrough Immuno-Science for Patients

76 Grant $53.95M

Nantes, France

Biotechnology Medical Devices +1

Apollomics

We are a biopharmaceutical company committed to the discovery and development of mono- and...

26 Post-IPO Equity $262.60M

Foster City, United State...

Biotechnology Health Care +1

Biotecnol Limited

Immunotherapies for Life

London, United Kingdom

Biotechnology Health Care +1

Innate Pharma

196 Post-IPO Secondary $276.10M

Marseille, France

Biopharma Biotechnology +1

Alpha Cancer Technologies Inc.

HARNESSING NATURE TO BEAT CANCER

Toronto, Canada

Biotechnology Pharmaceutical

Cybrexa Therapeutics

Changing the paradigm for cancer treatment through the development of antigen-independent...

11 Series B $44.40M

New Haven, United States

Biotechnology Health and Wellness +1

Prescient Therapeutics

A clinical stage oncology company developing personalised medicine approaches to cancer; c...

14 Post-IPO Equity $3.00M

Australia

Biopharma Biotechnology +3

About Immunovo B.V.

Immunovo, founded in 2009, is a Dutch biotechnology company focused on advancing cancer treatment through pioneering immune activation technology. The company's primary emphasis lies in its proprietary Immune Activation System (IAS), which combines synthetic peptide antigens with a novel immune stimulant (adjuvant). Im...

Business keywords

Oncology, Immunotherapy, Cancer Treatment, Immune Activation, Clinical Development, Adjuvant, Immunotherapeutics, Synthetic Peptide Antigens, Dutch Biotech Company, Immuno-Oncology, Immune Stimulant, Private Company, Innovation, Therapy Development

Frequently Asked Questions

Companies similar to Immunovo B.V. include Apexigen, Memgen, Inc., OncoPep, Inc., Bolt Biotherapeutics, Inc., Brenus Pharma. They work in Biotechnology and Pharmaceutical and share Immunovo B.V.'s focus on immunotherapy, cancer treatment and immuno-oncology.

Bounce Watch lists 12 companies that share Immunovo B.V.'s industries and are closest to it in business tags, services, target customers, business model and size.

Don't just read about them. Follow them.

BounceWatch watches Immunovo B.V. and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Immunovo B.V. Profile Apexigen Alternatives Memgen, Inc. Alternatives OncoPep, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Immunovo B.V. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.